Abstract:ObjectiveTo investigate current practice, management and awareness of pediatric off-label drug use in China, and provide a reference for the effective management on pediatric off-label drug use.MethodsIt was a cross-sectional study.Pediatricians, pharmacists, nurses and medical section staffs from hospitals with pediatric qualification in 31 provinces of mainland China were recruited in the present study.An online anonymous questionnaire was designed by expert group of pediatricians, pharmacists, epidemiologists and pharmacy administration experts.The questionnaire consisted of 3 sections.The first section focused on participants'' general information (6 questions).The second section focused on practice and management of off-label drug use in the participants'' units (11 questions).The third section focused on awareness of medical professionals regarding off-label drug use and the Chinese Expert Consensus of Pediatric Off-Label Drug Use (33 questions).Results2 116 questionnaires were collected from 436 hospitals from 31 provinces including 36 specialized children''s hospitals, 50 maternal and child health hospitals and 350 general hospitals.The 436 hospitals comprised 20 primary hospitals, 185 secondary hospitals and 231 tertiary hospitals.2 116 respondents included 621pediatricians, 755 pharmacists, 531 nurses and 209 medical section staffs.63.8% of the pediatricians had off-label drug prescription experience and 18.8% of the pediatricians prescribed off-label drugs often.Pediatricians with higher technical titles prescribed off-label drugs more frequently.19.4% of the pediatricians were not reminded by pharmacists or nurses during the prescription.It was common for pharmacists to find off-label prescription regardless of the professional title (87.1%~98.3%) and hospital grade (82.1%~94.2%).6.9%~8.8% of the nurses refused to executive off-label prescription.60.6% of the participating hospitals had established protocols for off-label use.The rates were higher in tertiary hospitals and specialized children''s hospitals.70% of the respondents felt it was not illegal to use off-label drugs.However, more than 80% of the respondents realized that there were potential risks to use off-label drugs.Pharmacists had the highest awareness rate of the "Expert Consensus of Pediatric Off-Label Drug Use" (56.8%).followed by pediatricians (51.2%), medical section staffs (45.4%) and nurses (35.8%).ConclusionPediatric off-label drug use is common in China and there exists gaps in the management of the issue.It is necessary to establish the national guidelines to regulate pediatric off-label drug use with Chinese national conditions and to strengthen the training of medical professional on using off-label drugs.

PAttern of drug use in PEdiatrics: An observational study in Italian hOSpitals (the PAPEOS study)

Survey of unlicensed and off label drug use in paediatric wards in European countries

Pediatric Off-Label and Unlicensed Drug Use and Its Implications

Trends in Off-Label Drug Use in Ambulatory Settings: 2006–2015

Off-label drug use in pediatric wards: a prospective study in a tertiary care hospital in Pune

Improving Drug Safety in Pediatric and Young Adult Patients with Hemato-Oncological Diseases: A Prospective Study of Active Pharmacovigilance

Off‑label and unapproved pediatric drug utilization: A meta‑analysis

Off-label use of antimicrobials among hospitalized children: a retrospective study of 3,406 patients

Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data

Antibiotic prescription in the outpatient paediatric population attending emergency departments in Lombardy, Italy: a retrospective database review

Prevalence of use of on-label and off-label psychotropics in the Greek pediatric population

The epidemiology of drug-related hospital admissions in paediatrics – a systematic review

Recommendations on Off-Label Drug Use in Pediatric Guidelines

Unlicensed/Off-Label Drug Prescriptions at Hospital Discharge in Children: An Observational Study Using Routinely Collected Health Data

Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society for Developmental Perinatal and Pediatric Pharmacology

Potentially inappropriate prescribing in hospitalised children: a retrospective, cross-sectional study at a tertiary children's hospital in China

Off-Label Pediatric Medication Prescribing and Dispensing: Awareness and Attitudes among Community Pharmacists: A Questionnaire-Based Study

Pediatric pharmaceutical interventions in self-medication: a descriptive study in community pharmacies

Paediatric off-label use of drugs in Gansu, China: a multicentre cross-sectional study

Serious Adverse Drug Reactions and Safety Signals in Children: A Nationwide Database Study

Current practice, management and awareness of pediatric off-label drug use in China-A questionnaire based cross-sectional survey